Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TaiNAC: Tailored vs Standard Neoadjuvant Chemotherapy in Breast Cancer
NCT00776724Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- May 2008
- Primary completion
- Nov 2014
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, epirubicin, Cisplatin micelle injection (HA132), vinorelbine, fluorouracil in breast cancer, sponsored by National Taiwan University Hospital. Started May 2008; status: completed.
02
Drugs
docetaxelepirubicinCisplatin micelle injection (HA132)vinorelbinefluorouracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00776724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00776724.